Effectiveness of paediatric asthma clinical pathways: A narrative systematic review

Kee Hsin Chen, Chiehfeng Chen, Hsueh Erh Liu, Pei Chuan Tzeng, Paul P. Glasziou

Research output: Contribution to journalArticleResearchpeer-review

12 Citations (Scopus)

Abstract

Objective: To evaluate the effectiveness of clinical pathways (CPs) for paediatric asthma on length of hospital stay, additional visits due to asthma exacerbations, hospital cost, manpower and workload required for implementing CPs. Methods: Studies were eligible if they met the following criteria: children (≤18 years) with asthma, hospital or emergency department based, and study designs were (1) randomised controlled trial, (2) controlled clinical trial or (3) controlled before and after study. Two reviewers independently screened references, extracted data and assessed the risk of bias. We resolved disagreement by discussion between authors. Due to an insufficient number of studies and the heterogeneity of interventions and outcomes, we conducted a narrative systematic review with forest plots but did not pool results. Results: About 3155 relevant articles were identified through a literature search, 628 were duplicates removed, 2037 were excluded based on review of titles and abstracts and 117 were excluded because they did not meet inclusion criteria. Seven studies involving 2600 participants met the inclusion criteria. Using asthma CPs may decrease the length of hospital stay; however, CPs did not appear to reduce additional visits due to asthma exacerbations or reduce hospital costs. No eligible studies were found that quantified the manpower and workload for implementing CPs. Conclusions: Current studies suggest CPs may reduce the length of hospital stay, but insufficient evidence is available on total costs or readmissions to justify extensive uptake of asthma CPs in paediatric inpatient care. Higher quality, large randomised controlled trials are required that measure costs and a wider range of outcomes.

Original languageEnglish
Pages (from-to)480-492
Number of pages13
JournalJournal of Asthma
Volume51
Issue number5
DOIs
Publication statusPublished - 2014

Fingerprint

Critical Pathways
Asthma
Length of Stay
Pediatrics
Hospital Costs
Workload
Randomized Controlled Trials
Costs and Cost Analysis
Hospital Departments
Controlled Clinical Trials
Hospital Emergency Service
Inpatients

Cite this

Chen, Kee Hsin ; Chen, Chiehfeng ; Liu, Hsueh Erh ; Tzeng, Pei Chuan ; Glasziou, Paul P. / Effectiveness of paediatric asthma clinical pathways : A narrative systematic review. In: Journal of Asthma. 2014 ; Vol. 51, No. 5. pp. 480-492.
@article{e3fe2fe38c7441b6babc7c71d43e7adb,
title = "Effectiveness of paediatric asthma clinical pathways: A narrative systematic review",
abstract = "Objective: To evaluate the effectiveness of clinical pathways (CPs) for paediatric asthma on length of hospital stay, additional visits due to asthma exacerbations, hospital cost, manpower and workload required for implementing CPs. Methods: Studies were eligible if they met the following criteria: children (≤18 years) with asthma, hospital or emergency department based, and study designs were (1) randomised controlled trial, (2) controlled clinical trial or (3) controlled before and after study. Two reviewers independently screened references, extracted data and assessed the risk of bias. We resolved disagreement by discussion between authors. Due to an insufficient number of studies and the heterogeneity of interventions and outcomes, we conducted a narrative systematic review with forest plots but did not pool results. Results: About 3155 relevant articles were identified through a literature search, 628 were duplicates removed, 2037 were excluded based on review of titles and abstracts and 117 were excluded because they did not meet inclusion criteria. Seven studies involving 2600 participants met the inclusion criteria. Using asthma CPs may decrease the length of hospital stay; however, CPs did not appear to reduce additional visits due to asthma exacerbations or reduce hospital costs. No eligible studies were found that quantified the manpower and workload for implementing CPs. Conclusions: Current studies suggest CPs may reduce the length of hospital stay, but insufficient evidence is available on total costs or readmissions to justify extensive uptake of asthma CPs in paediatric inpatient care. Higher quality, large randomised controlled trials are required that measure costs and a wider range of outcomes.",
author = "Chen, {Kee Hsin} and Chiehfeng Chen and Liu, {Hsueh Erh} and Tzeng, {Pei Chuan} and Glasziou, {Paul P.}",
year = "2014",
doi = "10.3109/02770903.2014.887728",
language = "English",
volume = "51",
pages = "480--492",
journal = "Journal of Asthma Research",
issn = "0021-9134",
publisher = "Informa Healthcare USA",
number = "5",

}

Effectiveness of paediatric asthma clinical pathways : A narrative systematic review. / Chen, Kee Hsin; Chen, Chiehfeng; Liu, Hsueh Erh; Tzeng, Pei Chuan; Glasziou, Paul P.

In: Journal of Asthma, Vol. 51, No. 5, 2014, p. 480-492.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Effectiveness of paediatric asthma clinical pathways

T2 - A narrative systematic review

AU - Chen, Kee Hsin

AU - Chen, Chiehfeng

AU - Liu, Hsueh Erh

AU - Tzeng, Pei Chuan

AU - Glasziou, Paul P.

PY - 2014

Y1 - 2014

N2 - Objective: To evaluate the effectiveness of clinical pathways (CPs) for paediatric asthma on length of hospital stay, additional visits due to asthma exacerbations, hospital cost, manpower and workload required for implementing CPs. Methods: Studies were eligible if they met the following criteria: children (≤18 years) with asthma, hospital or emergency department based, and study designs were (1) randomised controlled trial, (2) controlled clinical trial or (3) controlled before and after study. Two reviewers independently screened references, extracted data and assessed the risk of bias. We resolved disagreement by discussion between authors. Due to an insufficient number of studies and the heterogeneity of interventions and outcomes, we conducted a narrative systematic review with forest plots but did not pool results. Results: About 3155 relevant articles were identified through a literature search, 628 were duplicates removed, 2037 were excluded based on review of titles and abstracts and 117 were excluded because they did not meet inclusion criteria. Seven studies involving 2600 participants met the inclusion criteria. Using asthma CPs may decrease the length of hospital stay; however, CPs did not appear to reduce additional visits due to asthma exacerbations or reduce hospital costs. No eligible studies were found that quantified the manpower and workload for implementing CPs. Conclusions: Current studies suggest CPs may reduce the length of hospital stay, but insufficient evidence is available on total costs or readmissions to justify extensive uptake of asthma CPs in paediatric inpatient care. Higher quality, large randomised controlled trials are required that measure costs and a wider range of outcomes.

AB - Objective: To evaluate the effectiveness of clinical pathways (CPs) for paediatric asthma on length of hospital stay, additional visits due to asthma exacerbations, hospital cost, manpower and workload required for implementing CPs. Methods: Studies were eligible if they met the following criteria: children (≤18 years) with asthma, hospital or emergency department based, and study designs were (1) randomised controlled trial, (2) controlled clinical trial or (3) controlled before and after study. Two reviewers independently screened references, extracted data and assessed the risk of bias. We resolved disagreement by discussion between authors. Due to an insufficient number of studies and the heterogeneity of interventions and outcomes, we conducted a narrative systematic review with forest plots but did not pool results. Results: About 3155 relevant articles were identified through a literature search, 628 were duplicates removed, 2037 were excluded based on review of titles and abstracts and 117 were excluded because they did not meet inclusion criteria. Seven studies involving 2600 participants met the inclusion criteria. Using asthma CPs may decrease the length of hospital stay; however, CPs did not appear to reduce additional visits due to asthma exacerbations or reduce hospital costs. No eligible studies were found that quantified the manpower and workload for implementing CPs. Conclusions: Current studies suggest CPs may reduce the length of hospital stay, but insufficient evidence is available on total costs or readmissions to justify extensive uptake of asthma CPs in paediatric inpatient care. Higher quality, large randomised controlled trials are required that measure costs and a wider range of outcomes.

UR - http://www.scopus.com/inward/record.url?scp=84901028914&partnerID=8YFLogxK

U2 - 10.3109/02770903.2014.887728

DO - 10.3109/02770903.2014.887728

M3 - Article

VL - 51

SP - 480

EP - 492

JO - Journal of Asthma Research

JF - Journal of Asthma Research

SN - 0021-9134

IS - 5

ER -